Mitomycin C for Injection

Active Ingredients: Mitomycin C

Mitomycin C for Injection is an anticancer drug used to treat upper gastrointestinal (e.g., esophageal carcinoma), rectal cancers, pancreatic, neck cancers, cervix cancers, lung cancers, and breast cancers. Mitomycin C can also be given via a bladder instillation for superficial bladder tumors.

Mitomycin C for Injection is an antineoplastic and antitumor antibiotic drug. It is derived from the microorganism, Streptomyces caespitosus. This drug works by binding the cancer cell's DNA together, which means that the cell cannot divide, and the cancer cells cannot grow further.

AdvaCare Pharma is the manufacturer and exporter of Mitomycin C for Injection. We routinely inspect our production facilities to ensure our products meet quality and safety standards. We offer a wide range of high-quality and cost-effective oncology medications that are available for distribution.

AdvaCare Pharma manufactures a variety of oncology medications, including Mitomycin C for Injection, at GMP-certified facilities. We are committed to producing cost-effective, high-quality cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. Our global reach extends to over 65 markets, where we supply our products to distributors, hospitals, pharmacies, NGOs, and government institutions.

What is Mitomycin C used for?

Mitomycin C can also be used to treat superficial bladder tumors when given via a bladder instillation.

How is Mitomycin C for Injection used?

This medication has been manufactured as a powder, which is stored in a vial. The powder is to be prepared into a solution, and after reconstitution, it should be administered by injection into a vein.

What dose should be given?

For stomach or pancreatic cancer, the usual dose is 20mg/m² IV, given on day 1 of a 42- or 56-day cycle. It is typically part of a multidrug chemotherapy treatment.

The exact dose for adults depends on the type of disease and the patient's general condition. Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

As with all pharmaceuticals, some unwanted effects can occur from the use of Mitomycin C for Injection.

For a comprehensive list of all possible effects, consult a doctor.

If any symptom persists or gets worse, or you notice any other symptom, please call your doctor immediately.

Consult with your doctor about your full medical history and current medications before your treatment with Mitomycin C for Injection.

There is little evidence with regards to the use of Mitomycin C during pregnancy or breastfeeding, so consult a doctor or healthcare professional before using it.

Driving or operating machinery is okay, as the medication should not cause dizziness or drowsiness.